β-Adrenergic Signaling, Monoamine Oxidase A and Antioxidant Defence in the Myocardium of SHR and SHR-mtBN Conplastic Rat Strains: the Effect of Chronic Hypoxia
Overview
Authors
Affiliations
The β-adrenergic signaling pathways and antioxidant defence mechanisms play important roles in maintaining proper heart function. Here, we examined the effect of chronic normobaric hypoxia (CNH, 10% O, 3 weeks) on myocardial β-adrenergic signaling and selected components of the antioxidant system in spontaneously hypertensive rats (SHR) and in a conplastic SHR-mtBN strain characterized by the selective replacement of the mitochondrial genome of SHR with that of the more ischemia-resistant Brown Norway strain. Our investigations revealed some intriguing differences between the two strains at the level of β-adrenergic receptors (β-ARs), activity of adenylyl cyclase (AC) and monoamine oxidase A (MAO-A), as well as distinct changes after CNH exposure. The β-AR/β-AR ratio was significantly higher in SHR-mtBN than in SHR, apparently due to increased expression of β-ARs. Adaptation to hypoxia elevated β-ARs in SHR and decreased the total number of β-ARs in SHR-mtBN. In parallel, the ability of isoprenaline to stimulate AC activity was found to be higher in SHR-mtBN than that in SHR. Interestingly, the activity of MAO-A was notably lower in SHR-mtBN than in SHR, and it was markedly elevated in both strains after exposure to hypoxia. In addition to that, CNH markedly enhanced the expression of catalase and aldehyde dehydrogenase-2 in both strains, and decreased the expression of Cu/Zn superoxide dismutase in SHR. Adaptation to CNH intensified oxidative stress to a similar extent in both strains and elevated the IL-10/TNF-α ratio in SHR-mtBN only. These data indicate that alterations in the mitochondrial genome can result in peculiar changes in myocardial β-adrenergic signaling, MAO-A activity and antioxidant defence and may, thus, affect the adaptive responses to hypoxia.
Ferko M, Alanova P, Janko D, Opletalova B, Andelova N Physiol Res. 2025; 73(6):887-900.
PMID: 39903882 PMC: 11835206.
Knittel J, Itani N, Schreckenberg R, Heger J, Rohrbach S, Schulz R Biomolecules. 2023; 13(6).
PMID: 37371593 PMC: 10296391. DOI: 10.3390/biom13061013.
Heger J, Szabados T, Brosinsky P, Bencsik P, Ferdinandy P, Schulz R Int J Mol Sci. 2023; 24(7).
PMID: 37047416 PMC: 10094730. DOI: 10.3390/ijms24076443.
Pravenec M, Silhavy J, Mlejnek P, Simakova M, Mracek T, Pecinova A Physiol Res. 2022; 70(Suppl4):S471-S484.
PMID: 35199537 PMC: 9054184. DOI: 10.33549/physiolres.934740.